Global Markets Advance; U.S. Biotech Shares Slip
Nasdaq Given the scale of recent declines, markets are liable to stage short-term rebounds unless additional bad news on the economy arrives, said Valentijn van Nieuwenhuijzen, head of multiasset investments at NN Investment Partners, which oversees EUR184 ... |
via http://ift.tt/1Qzt61G
Geen opmerkingen:
Een reactie posten